Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.625 USD | -9.12% | -19.93% | -64.76% |
10/05 | Annovis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Annovis Bio, Inc. Announces Unblinding of the Buntanetap Phase III Data in Parkinson?s Disease | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.76% | 81.44M | |
+9.96% | 118B | |
+10.30% | 106B | |
-11.38% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.46% | 15.97B | |
+6.79% | 14.03B | |
+17.88% | 11.67B |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- Transcript : Annovis Bio, Inc. - Special Call